X. Sheng

发表

Novel, potent and orally bioavailable indolizidinone-derived inhibitors of the hepatitis C virus NS3 protease.

S. Leavitt, Xiaowu Chen, M. Clarke, 2012, Bioorganic & medicinal chemistry letters.

Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease.

W. Delaney, Xiaowu Chen, M. Clarke, 2011, Bioorganic & medicinal chemistry letters.

Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease.

T. Appleby, W. Delaney, Ruby Z Cai, 2012, Bioorganic & medicinal chemistry letters.

Discovery of GS-9256: a novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity.

W. Delaney, Ruby Z Cai, Xiaowu Chen, 2012, Bioorganic & medicinal chemistry letters.

Preclinical Characterization of the Novel HCV NS3 Protease Inhibitor GS-9256

H. Mo, Huiling Yang, W. Delaney, 2017, Antiviral therapy.

Synthesis and resolution of diethyl (1S,2S)-1-amino-2-vinylcyclopropane-1-phosphonate for HCV NS3 protease inhibitors

J. R. Somoza, C. Kim, K. Chaudhary, 2009 .

Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors.

W. Delaney, Xiaowu Chen, Edward M. Doerffler, 2009, Bioorganic & Medicinal Chemistry Letters.

Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease.

Huiling Yang, Neeraj Tirunagari, T. Kirschberg, 2014, Bioorganic & medicinal chemistry letters.

Discovery of GS-9256: A Novel Phosphinic Acid Derived Inhibitor (I) of the Hepatitis C Virus NS3/4A Protease with Potent Clinical Activity.

X. Sheng, 2012 .

Synthesis of 1-amino-2-vinylcyclopropane-1-phosphinates. Conversion of a phosphonate to phosphinates

M. Clarke, Anthony D. Casarez, C. Kim, 2012 .

Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451

H. Mo, Huiling Yang, W. Delaney, 2013, Antimicrobial Agents and Chemotherapy.

Heterocyclic antiviral compounds having phosphonate groups

D. Mcmurtrie, C. Kim, K. Chaudhary, 2005 .